Endoplasmic Reticulum Mitochondrial membranes in Alzheimer's disease
Endoplasmic Reticulum Mitochondrial membranes in Alzheimer's disease
批准号:
9484212
负责人:
Estela Area Gomez
金额:
$11.34万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-01 至 2019-05-31
关键词:
AffectAlzheimer&aposs DiseaseAmyloid beta-ProteinAmyloid beta-Protein PrecursorAnimal ModelAreaAttentionAwardBasic ScienceBiochemicalBrainC-terminalCalciumCell LineCell membraneCell modelCellsCerebellumCholesterolCholesterol EstersCholesterol HomeostasisCleaved cellCommunicationComplexDiagnosisDiseaseEndoplasmic ReticulumEventFibroblastsFunctional disorderFundingFutureGoalsHippocampus (Brain)HomeostasisHumanInvestigationKnock-in MouseKnowledgeLengthLipidsMeasuresMembraneMembrane MicrodomainsMentorshipMitochondriaMorphologyMusMutationN-terminalNerve DegenerationNeurodegenerative DisordersNeurofibrillary TanglesNeuronsPathogenesisPatientsPhenotypePhospholipid MetabolismPhospholipidsPlasmidsProcessRegulationResearch Project GrantsRoleSenile PlaquesSourceSpecificityThinkingTissuesUp-RegulationWorkbasebeta secretasebeta-site APP cleaving enzyme 1careercrosslinkextracellularfollow-upgamma secretasehuman tissuehyperphosphorylated tauinduced pluripotent stem cellinsightmembrane activitymitochondrial membraneneuroblastoma cellneuron lossnicastrin proteinnovelpresenilinpresenilin-1presenilin-2public health relevanceskillsstem cell differentiationtau Proteins
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Alzheimer disease (AD) is characterized by neuronal loss, especially in the cortex and hippocampus, accompanied by accumulation in the brain of extracellular neuritic plaques containing ß-amyloid (Aß) and of intracellular neurofibrillary tangles consisting of hyperphosphorylated tau protein. AD patients also present with other features that have received less attention, including aberrant cholesterol, phospholipid, and calcium homeostasis, and altered mitochondrial function and dynamics. Presenilin-1 (PS1), presenilin-2 (PS2), and γ-secretase activity, which processes the amyloid precursor protein (APP) to generate Aß, are all located predominantly in a specialized subcompartment of the endoplasmic reticulum (ER) that is physically and biochemically connected to mitochondria, called mitochondria-associated ER membranes (MAM). MAM is involved in the regulation of cholesterol and phospholipid metabolism, calcium homeostasis, and in mitochondrial function and dynamics. Recently, we showed that MAM is lipid raft-like domain and that cells from AD patients have massively upregulated MAM activity and increased ER mitochondrial connectivity, resulting in altered cholesterol, phospholipid and calcium homeostasis, and aberrant mitochondrial dynamics, which may help explain many of the biochemical and morphological features of the disease. Based on these findings, we believe that MAM dysfunction and altered ER-mitochondrial connectivity are early causative events in the pathogenesis of AD. We now propose studies aimed at understanding MAM function from a basic science standpoint, with the ultimate goal of applying this knowledge translationally. Specifically, we will (1) analyze MAM function in cells and tissues that are more "AD-relevant," including PS-deficient human neuroblastoma cells, human induced pluripotent stem cells differentiated into neurons, and tissues and neurons explanted from PS1 knock-in mice; (2) analyze presenilins and γ-secretase regulation in MAM versus other compartments, such as "bulk" ER or the plasma membrane, while also assessing the role of other components (e.g. APH-1, nicastrin, PEN2) and regulators (e.g. CD147, GSAP, and TMP21) of the γ-secretase complex; and (3) understand the role of ER-mitochondrial communication in the pathogenesis of AD, by tethering ER to mitochondria at various fixed distances, using novel ER-mitochondria "crosslinking" plasmids, in order to mimic ER-mitochondrial connectivity in a presenilin-independent manner.
期刊论文(11)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
The Alzheimer's disease-associated C99 fragment of APP regulates cellular cholesterol trafficking.
阿尔茨海默氏病与APP相关的C99碎片调节细胞胆固醇的运输。
DOI:
10.15252/embj.2019103791
发表时间:
2020-10-15
期刊:
The EMBO journal
影响因子:
--
作者:
[Montesinos J, Pera M, Larrea D, Guardia-Laguarta C, Agrawal RR, Velasco KR, Yun TD, Stavrovskaya IG, Xu Y, Koo SY, Snead AM, Sproul AA, Area-Gomez E]
通讯作者:
Area-Gomez E
DOI:
10.1016/j.gde.2016.04.006
发表时间:
2016-06
期刊:
Current opinion in genetics & development
影响因子:
4
作者:
[Area-Gomez E, Schon EA]
通讯作者:
Schon EA
DOI:
10.1016/j.disamonth.2010.06.001
发表时间:
2010-09
期刊:
Disease-a-month : DM
影响因子:
--
作者:
[Castellani RJ, Rolston RK, Smith MA]
通讯作者:
Smith MA
DOI:
10.3389/fnana.2015.00017
发表时间:
2015
期刊:
Frontiers in neuroanatomy
影响因子:
2.9
作者:
[Guardia-Laguarta C, Area-Gomez E, Schon EA, Przedborski S]
通讯作者:
Przedborski S
The fat brain.
脑子胖了。
DOI:
10.1097/mco.0000000000000634
发表时间:
2020
期刊:
Current opinion in clinical nutrition and metabolic care
影响因子:
3.1
作者:
[Montesinos,Jorge, Guardia-Laguarta,Cristina, Area-Gomez,Estela]
通讯作者:
Area-Gomez,Estela
Investigating the convergence of AD genetics on lipid metabolism and microglia regulation
-
批准号:10288338
-
项目类别:
-
资助金额:$43.12万
-
财政年份:2021
-
负责人:Estela Area Gomez
-
依托单位:
Endoplasmic Reticulum Mitochondrial membranes in Alzheimer's disease
-
批准号:8767203
-
项目类别:
-
资助金额:$11.34万
-
财政年份:2014
-
负责人:Estela Area Gomez
-
依托单位: